List of works - Arati Sharma

Acid ceramidase is upregulated in AML and represents a novel therapeutic target

scientific article

Akt3 and mutant V600E B-Raf cooperate to promote early melanoma development.

scientific article published on May 2008

Current State of Animal (Mouse) Modeling in Melanoma Research

scientific article

Downregulation of CD73 associates with T cell exhaustion in AML patients

scientific article published on 24 April 2019

Identification of WEE1 as a target to make AKT inhibition more effective in melanoma.

scientific article

Identification of glycogen synthase kinase 3α as a therapeutic target in melanoma

scientific article

Improving pharmacological targeting of AKT in melanoma.

scientific article published on 10 July 2017

Leelamine mediates cancer cell death through inhibition of intracellular cholesterol transport.

scientific article

Loss of PTEN promotes tumor development in malignant melanoma

scientific article published on 01 June 2003

Macrophage inhibitory cytokine-1 regulates melanoma vascular development

scientific article

Method of mutation analysis may contribute to discrepancies in reports of (V599E)BRAF mutation frequencies in melanocytic neoplasms

scientific article published on 01 November 2004

Models of melanoma metastasis: using a transient siRNA-based protein inhibition strategy in mice to validate the functional relevance of pharmacological agents.

scientific article published on September 2007

Nanolipolee-007, a novel nanoparticle-based drug containing leelamine for the treatment of melanoma.

scientific article

Nanoparticle-Based Celecoxib and Plumbagin for the Synergistic Treatment of Melanoma.

scientific article published on 21 December 2016

Optimizing live-animal bioluminescence imaging prediction of tumor burden in human prostate cancer xenograft models in SCID-NSG mice

scientific article published on 08 April 2019

Propagation of Undifferentiated Human Embryonic Stem Cells with Nano-Liposomal Ceramide

scientific article published in January 2009

Realizing the clinical potential of cancer nanotechnology by minimizing toxicologic and targeted delivery concerns

scientific article

Robust activation of the human but not mouse telomerase gene during the induction of pluripotency.

scientific article

Schweinfurthin natural products induce regression of murine melanoma and pair with anti-PD-1 therapy to facilitate durable tumor immunity

scientific article published on 11 November 2018

Synergistic inhibitory effects of Celecoxib and Plumbagin on melanoma tumor growth.

scientific article published on 18 October 2016

Synthesis and characterization of a novel iNOS/Akt inhibitor Se,Se'-1,4-phenylenebis(1,2-ethanediyl)bisisoselenourea (PBISe)--against colon cancer.

scientific article published on 22 September 2009

Systemic delivery of liposomal short-chain ceramide limits solid tumor growth in murine models of breast adenocarcinoma.

scientific article

Targeting V600EB-Raf and Akt3 using nanoliposomal-small interfering RNA inhibits cutaneous melanocytic lesion development.

scientific article

Targeting multiple key signaling pathways in melanoma using leelamine.

scientific article

The novel Isatin analog KS99 targets stemness markers in acute myeloid leukemia

scientific article published on 23 May 2019

Transiently entrapped circulating tumor cells interact with neutrophils to facilitate lung metastasis development

scientific article

eEF-2 kinase dictates cross-talk between autophagy and apoptosis induced by Akt Inhibition, thereby modulating cytotoxicity of novel Akt inhibitor MK-2206.

scientific article published on 9 February 2011

List of works by Arati Sharma

Acid ceramidase is upregulated in AML and represents a novel therapeutic target

Akt3 and mutant V600E B-Raf cooperate to promote early melanoma development.

Current State of Animal (Mouse) Modeling in Melanoma Research

Downregulation of CD73 associates with T cell exhaustion in AML patients

Identification of WEE1 as a target to make AKT inhibition more effective in melanoma.

Identification of glycogen synthase kinase 3α as a therapeutic target in melanoma

Improving pharmacological targeting of AKT in melanoma.

Leelamine mediates cancer cell death through inhibition of intracellular cholesterol transport.

Loss of PTEN promotes tumor development in malignant melanoma

Macrophage inhibitory cytokine-1 regulates melanoma vascular development

Method of mutation analysis may contribute to discrepancies in reports of (V599E)BRAF mutation frequencies in melanocytic neoplasms

Models of melanoma metastasis: using a transient siRNA-based protein inhibition strategy in mice to validate the functional relevance of pharmacological agents.

Nanolipolee-007, a novel nanoparticle-based drug containing leelamine for the treatment of melanoma.

Nanoparticle-Based Celecoxib and Plumbagin for the Synergistic Treatment of Melanoma.

Optimizing live-animal bioluminescence imaging prediction of tumor burden in human prostate cancer xenograft models in SCID-NSG mice

Propagation of Undifferentiated Human Embryonic Stem Cells with Nano-Liposomal Ceramide

Realizing the clinical potential of cancer nanotechnology by minimizing toxicologic and targeted delivery concerns

Robust activation of the human but not mouse telomerase gene during the induction of pluripotency.

Schweinfurthin natural products induce regression of murine melanoma and pair with anti-PD-1 therapy to facilitate durable tumor immunity

Synergistic inhibitory effects of Celecoxib and Plumbagin on melanoma tumor growth.

Synthesis and characterization of a novel iNOS/Akt inhibitor Se,Se'-1,4-phenylenebis(1,2-ethanediyl)bisisoselenourea (PBISe)--against colon cancer.

Systemic delivery of liposomal short-chain ceramide limits solid tumor growth in murine models of breast adenocarcinoma.

Targeting V600EB-Raf and Akt3 using nanoliposomal-small interfering RNA inhibits cutaneous melanocytic lesion development.

Targeting multiple key signaling pathways in melanoma using leelamine.

The novel Isatin analog KS99 targets stemness markers in acute myeloid leukemia

Transiently entrapped circulating tumor cells interact with neutrophils to facilitate lung metastasis development

eEF-2 kinase dictates cross-talk between autophagy and apoptosis induced by Akt Inhibition, thereby modulating cytotoxicity of novel Akt inhibitor MK-2206.